“…Scheme 1 is a generic synthetic methodology for the preparation of C 2 -symmetric DEAM diazolium triflate salts [17,18,65,66]. The synthesis of the diazolium salts (S,S)-trans-1,1 0 -(9,10-dihydro-9,10-ethanoanthracene-11,12-diyldimethanediyl)bis(3-(2-methylphenyl-1-benzyl)-1H-benzimidazol-3-ium)bis(triflouromethansulfonate) [DEAM-o-MBBI][OTf] 2 (3) and (S,S,R,R)-trans-1,1 0 -(9,10-dihydro-9,10-ethanoanthracene-11,12-diyldimethanediyl)bis(3-(R-1-phenylethane)-1H-imidazol-3-ium) [DEAM-PEI][OTf] 2 (4) involves treating two equivalents of 1-benzyl(2-methylphenyl)-benzimidazole (1) or R-1-(1-phenylethyl)-1H-imidazole (2) [75] with an equivalent of (S,S)-trans-9,10-dihydro-9,10-ethanoanthracene-11,12-diyldimethanediyl bis(trifluoromethanesulfonate) [76] in refluxing DME.…”